CL2014002033A1 - Compuestos derivados de dihidrofurano-azetidina y sus sales; composicion farmaceutica o veterinaria que los comprende; y su uso para tratar una infeccion o infestacion parasitaria. - Google Patents

Compuestos derivados de dihidrofurano-azetidina y sus sales; composicion farmaceutica o veterinaria que los comprende; y su uso para tratar una infeccion o infestacion parasitaria.

Info

Publication number
CL2014002033A1
CL2014002033A1 CL2014002033A CL2014002033A CL2014002033A1 CL 2014002033 A1 CL2014002033 A1 CL 2014002033A1 CL 2014002033 A CL2014002033 A CL 2014002033A CL 2014002033 A CL2014002033 A CL 2014002033A CL 2014002033 A1 CL2014002033 A1 CL 2014002033A1
Authority
CL
Chile
Prior art keywords
dihydrofuran
infestation
azetidine
treat
pharmaceutical
Prior art date
Application number
CL2014002033A
Other languages
English (en)
Inventor
Nathan Anthony Logan Chubb
Valerie Vaillancourt
Original Assignee
Zoetis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47679106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014002033(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Llc filed Critical Zoetis Llc
Publication of CL2014002033A1 publication Critical patent/CL2014002033A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CL2014002033A 2012-02-03 2014-07-30 Compuestos derivados de dihidrofurano-azetidina y sus sales; composicion farmaceutica o veterinaria que los comprende; y su uso para tratar una infeccion o infestacion parasitaria. CL2014002033A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261594569P 2012-02-03 2012-02-03

Publications (1)

Publication Number Publication Date
CL2014002033A1 true CL2014002033A1 (es) 2014-10-03

Family

ID=47679106

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002033A CL2014002033A1 (es) 2012-02-03 2014-07-30 Compuestos derivados de dihidrofurano-azetidina y sus sales; composicion farmaceutica o veterinaria que los comprende; y su uso para tratar una infeccion o infestacion parasitaria.

Country Status (14)

Country Link
US (1) US9133172B2 (es)
EP (1) EP2814825B1 (es)
JP (1) JP5997779B2 (es)
CN (1) CN104169273B (es)
AR (1) AR092792A1 (es)
AU (1) AU2013215368A1 (es)
BR (1) BR112014018650A8 (es)
CA (1) CA2863625C (es)
CL (1) CL2014002033A1 (es)
ES (1) ES2571444T3 (es)
MX (1) MX336430B (es)
PL (1) PL2814825T3 (es)
RU (1) RU2014131951A (es)
WO (1) WO2013116230A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6049866B2 (ja) * 2012-05-09 2016-12-21 ゾエティス・サービシーズ・エルエルシー 駆虫剤としてのアゼチジン誘導体
CA2881844A1 (en) * 2012-09-07 2014-03-13 Zoetis Llc Spirocyclic derivatives as antiparasitic agents
MX370163B (es) * 2015-01-16 2019-12-04 Avista Pharma Solutions Inc Compuestos antiparasitarios.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW524667B (en) 1996-12-05 2003-03-21 Pfizer Parasiticidal pyrazoles
JP2007501781A (ja) * 2003-08-07 2007-02-01 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 駆虫及び殺虫ピリミジン誘導体
GB0329314D0 (en) 2003-12-18 2004-01-21 Pfizer Ltd Substituted arylpyrazoles
TW200538433A (en) * 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
TW200803740A (en) * 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
CN101331127B (zh) * 2005-12-16 2012-05-23 杜邦公司 用于防治无脊椎害虫的5-芳基异噁唑啉
DE602007006288D1 (de) 2006-03-10 2010-06-17 Nissan Chemical Ind Ltd Substituierte isoxazolin-verbindung und schädlingsbekämpfungsmittel
WO2008122375A2 (en) * 2007-04-10 2008-10-16 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
KR20100064382A (ko) 2007-09-10 2010-06-14 닛산 가가쿠 고교 가부시키 가이샤 치환 이속사졸린 화합물 및 유해생물 방제제
CN102131804B (zh) * 2008-08-22 2014-12-03 先正达参股股份有限公司 杀虫化合物
JP2013520403A (ja) * 2010-02-22 2013-06-06 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物としてのジヒドロフラン誘導体
BR112013002871B1 (pt) * 2010-08-05 2018-11-21 Zoetis Llc derivados de isoxazolina, seu uso e composição farmacêutica ou veterinária

Also Published As

Publication number Publication date
JP5997779B2 (ja) 2016-09-28
AR092792A1 (es) 2015-05-06
RU2014131951A (ru) 2016-03-27
PL2814825T3 (pl) 2016-08-31
WO2013116230A1 (en) 2013-08-08
CN104169273B (zh) 2016-11-02
AU2013215368A1 (en) 2014-08-21
BR112014018650A2 (es) 2017-06-20
ES2571444T3 (es) 2016-05-25
BR112014018650A8 (pt) 2017-07-11
JP2015511233A (ja) 2015-04-16
US9133172B2 (en) 2015-09-15
CA2863625A1 (en) 2013-08-08
CN104169273A (zh) 2014-11-26
MX336430B (es) 2016-01-18
EP2814825A1 (en) 2014-12-24
EP2814825B1 (en) 2016-03-23
MX2014009387A (es) 2014-08-27
CA2863625C (en) 2016-04-26
US20150038440A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
SMT201700052B (it) 2-(azaindol-2-il)benzimidazoli come inibitori di pad4
CL2014003136A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos.
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
PE20151067A1 (es) Inhibidores de autotaxina
BR112016005262A2 (pt) Compostos aril éteres, uso dos mesmos e composição farmacêutica que os compreende
BR112016000489A2 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
DK2841429T3 (da) Tetrazolinonforbindelser og anvendelse deraf som pesticider
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
UY35467A (es) Compuestos orgánicos
BR112015001596A2 (pt) composição para o tratamento de hiperlipidemia que compreende oxintomodulina.
CL2014003472A1 (es) Pro-farmacos derivados de (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)acrilamida; composicion farmaceutica que los comprende; y su uso para tratar una infeccion bacteriana.
BR112015023417A2 (pt) compostos heterocíclicos e seus usos
CO6940429A2 (es) Compuestos heterocíclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparación
BR112016025659A2 (pt) compostos, seus usos, e composições farmacêuticas para induzir condrogênese
CL2014000490A1 (es) Compuestos derivados de pirazol y sus sales, con actividad inhibidora de sglt1; composicion farmaceutica que los comprende; y su uso para tratar o prevenir diabetes.
CO6852077A2 (es) Composiciónes que comprenden ditiínas sustituidas fungicidas y compuestos activos adicionales
BR112015002824A2 (pt) composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação.
CR20140263A (es) Composicion herbicida que contiene acido de 4-amino-3-cloro-6-(-4-cloro-2-fluor-3-metoxifenil) piridina-2-carboxilico, o los derivados del mismo y fluroxipir, o los derivados del mismo
CL2014000393A1 (es) Compuestos derivados de benzofurano y sus sales, como inhibidores del virus de hepatitis c; composicion farmaceutica que los comprende; y su uso para el tratamiento o la prevencion de una infeccion por el virus de hepatitis c o de una enfermedad asociada con dicha infeccion.
DK3258938T3 (da) Phenothiazinanaloger som mitokondrie terapeutiske midler
CL2014001862A1 (es) Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
CL2014002951A1 (es) (r)-nifuratel; formulacion farmaceutica que lo contiene; y proceso para fabricar (r)-nifuratel y (s)-nifuratel.
CL2014003495A1 (es) Agentes herbicidas que contienen flufenacet.
CR20180089A (es) Compuestos útiles para inhibir a ror-gamma-t